title: Mitral valve prolapse in Marfan syndrome: an old topic revisited.
abstract: BACKGROUND
  The echocardiographic features of mitral valve prolapse (MVP) in Marfan syndrome have been well described, and the incidence of MVP in Marfan syndrome is reported to be 40-80%. However, most of the original research was performed in the late 1980s and early 1990s, when the diagnostic criteria for MVP were less specific. Our goal was to investigate the characteristics of MVP associated with Marfan syndrome using currently accepted diagnostic criteria for MVP.
  
  
  METHODS
  Between January 1990 and March 2004, 90 patients with definitive diagnosis of Marfan syndrome (based on standardized criteria with or without genetic testing) were referred to Massachusetts General Hospital for transthoracic echocardiography. Patients' gender, age, weight, height, and body surface area at initial examination were recorded. Mitral valve thickness and motion, the degree of mitral regurgitation and aortic regurgitation, and aortic dimensions were quantified blinded to patients' clinical information.
  
  
  RESULTS
  There were 25 patients (28%) with MVP, among whom 80% had symmetrical bileaflet MVP. Patients with MVP had thicker mitral leaflets (5.0 +/- 1.0 mm vs. 1.8 +/- 0.5 mm, P < 0.001), more mitral regurgitation (using a scale of 1-4, 2.2 +/- 1.0 vs. 0.90 +/- 0.60, P < 0.0001), larger LVEDD, and larger dimensions of sinus of Valsalva, sinotubular junction, aortic arch, and descending aorta indexed to square root body surface area, when compared with those without MVP. When echocardiographic features of patients younger than 18 years of age and those of patients older than 18 were compared, adult Marfan patients had larger LA dimension (indexed to square root body surface area), larger sinotubular junction (indexed to square root body surface area), and more mitral regurgitation and aortic regurgitation.
  
  
  CONCLUSIONS
  The prevalence of MVP in Marfan syndrome is lower than previously reported. The large majority of patients with MVP have bileaflet involvement, and those with MVP have significantly larger aortic root diameters, suggesting a diffuse disease process.
authors.affiliation: Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. ctaub05@yahoo.com
authors.forename: Cynthia C
authors.initials: CC
authors.lastname: Taub
authors.forename: Joan M
authors.initials: JM
authors.lastname: Stoler
authors.forename: Teresa
authors.initials: T
authors.lastname: Perez-Sanz
authors.forename: John
authors.initials: J
authors.lastname: Chu
authors.forename: Eric M
authors.initials: EM
authors.lastname: Isselbacher
authors.forename: Michael H
authors.initials: MH
authors.lastname: Picard
authors.forename: Arthur E
authors.initials: AE
authors.lastname: Weyman
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008382:Marfan Syndrome / Q000150:complications* / Q000000981:diagnostic imaging*; D008875:Middle Aged; D008945:Mitral Valve Prolapse / Q000150:complications* / Q000000981:diagnostic imaging*; D014463:Ultrasonography; D055815:Young Adult